Short-term effect of nebivolol on the left ventricular diastolic function;Nebivololün sol ventrikül diyastolik fonksiyonlari üzerine erken dönem etkisi

Anadolu Kardiyoloji Dergisi

Volumn 4, Issue 4, 2004, Pages 323-326

  Demiralp, Ergün ^a   Kardeşoǧlu, Ejder ^a   Çelik, Turgay ^a   Cebeci, Bekir Sitki ^a   Özmen, Namik ^a   Işilak, Zafer ^a   Ulusoy, Rifat Eralp ^a   Dinçtürk, Mehmet ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Hypertension; Left ventricle diastolic functions; Nebivolol

Indexed keywords

NEBIVOLOL;

A WAVE; ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BORDERLINE HYPERTENSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECELERATION; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HUMAN; MALE; RANK SUM TEST; RELAXATION TIME; STATISTICAL SIGNIFICANCE; VELOCITY;

EID: 10644223574     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pauwels PJ, Gommeren W, Van Lommen G, Janssen PAJ, Leysen JE. The receptor binding profile of the new anti hypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blokers. Mol Pharmacol 1988; 34: 843-51.
2. Van de Water A, Janssens W, Van Nueten J, Xhonneoux R, De Cree L. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent and selective, b1-adrenergic antagonist J Cardiovasc Pharmacol 1988; 2: 552-63
3. Janssens WJ, Van de Water A, Xhonneux R, Reneman RS, Van Nueten JM, Janssen P. A. Nebivolol is devoid of intrinsic sympathomimetic activity. Eur J Pharmacol 1989; 159: 89-95.
4. Bowman AJ, Chen CPL-H, Ford GA. Nitric oxide mediated venodilator effects of nebivolol. Br J Clin Pharmacol 1994; 38: 199-204.
5. Cockoft JR, Chowienczyk PJ, Brett AE, et al. Nebivolol vasodilates human forearm vasculature; evidence for an L -arginine/NO-dependent mechanism J Pharmacol Exp Ther 1995; 274: 1067-71.
6. Dawes M, Brett SE, Chowienczyk PJ, Mant TG, Ritter JM. The vasodilator action of nebivolol in forearm vasculature of subjects with hypertension, Br J Clin Pharmacol 1999; 48: 460-3.
7. Stoleru L, Wijns W, van Eyll C, Bouvy T, van Nueten L, Pouleur H. Effects of D-nebivolol and L-nebiviolol on left ventricular systolic and diastolic function; comparison with D-L- nebivolol and atenolol. J Cardiovasc Pharmacol 1993; 2; 183-90.
8. Rousseau MF, Chapelle F, Van Eyll C, et al. Medium-term effects of b-blockade on left ventricular mechanism; a double -blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. J Card Failure 1996; 21; 15-23.
9. Van de Water A, Janssens W, Van Neuten J, et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist. J Cardiovasc Pharmacol 1988; 11: 552-63.
10. De Cree J, Geukens H, Verhaegen H. Non-invasive cardiac heamodynamics of nebivolol. An overview. Drug Invest 1991; 3; 40-50.
11. Goldstein M, Vincent JL, De Smet JM, et al. Administration of nebivolol after coronary artery bypass in patients with altered left ventricular function. J Cardiovasc Pharmacol 1993; 22; 253-8.
12. Wisenbaugh T, Katz I, Davis J, et al. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 1993; 21: 1094-100.
13. Himmelman A, Hedner T, Lundgren B, Snoeck E. Haemodynamic effects and pharmacokinetics of oral D-and L-nebivolol in hypertensive patients. Eur J Pharmacol 1996; 51; 259-64.
14. Blanketjin PJ. Nebivolol. An acute and long-term study in essential hypertension. Drug Invest 1991; 3(Suppl): 152-4.
15. Brune S, Schmidt T, Tebbe U, Kreuzer H. Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure. Angiology 1990; 41: 696-701.
16. Van Moredo T. Verapamil and nebivolol improve carotid artery distensibility in hypertensive patients. J Hypertens 1989; 7 (suppl 6); 262-3.
17. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003: 21; 289: 2560-72.
18. Schiller NB, Sbah PM, Crawfort M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358-67.
19. Briwius K, Brundkirchen, Block B, Menhorn U, Schwinger RHG. Nebivolol, bucindolol, metoprolol, and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium. Br J Pharmacol 2001; 133: 1330-58.
20. De Cree J. Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol, and nebivolol in normal volunteers. Int J Clin Pharmacol Res 1992; 12: 159-63.
21. Inouye I. Abnormal left ventricular filling: an early finding in mild moderate systemic hypertension. Am J Cardiol 1984; 53: 120-6.
22. Kamp O, Sieswerda GT, Visserb CA. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension. Am J Cardiol 2003; 92: 344-8.
23. McNeely YW, Goa KL. Nebivolol in the management of essential hypertension. A review. Drugs 1999; 57; 633-51.
24. Jennigs G, Esler M, Dart A. Effects of nebivolol on haemodynamics, cardiac dimension and function, cardiovascular reflexes and biochemical measures of sympathetic activity in normal human subjects. Drug Invest 1991; 3; 51-9.
25. Fouad E, Ouyang SP. Evaluation of left ventricular function assessed with Doppler echocardiography and radionuclide ventriculography after chronic treatment with nebivolol and atenolol. JRF clinical research Report on NEB-USA-1994.